Search research articles
Contact Us
Filters
Showing results (451-460 of 524) with videos related to
Page
of 53
Sort By:
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancer
Ray Pillai, Sarah E LeBoeuf, Yuan Hao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2021
<i>KRAS</i> <sup>G12C</sup> Mutation Is Associated with Increased Risk of Recurrence in Surgically Resected Lung Adenocarcinoma
Gregory D Jones, Raul Caso, Kay See Tan, et al.
Oncotarget
|
October 29, 2013
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine
John Wrangle, Wei Wang, Alexander Koch, et al.
Cancer Discovery
|
July 5, 2022
PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry
Amish J Patel, Sarah Warda, Jesper L V Maag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2023
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, et al.
The New England Journal of Medicine
|
September 29, 2015
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
Hossein Borghaei, Luis Paz-Ares, Leora Horn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2023
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis
Andreas Rimner, Zachary R Moore, Stephanie Lobaugh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2024
Lung cancer research and treatment: global perspectives and strategic calls to action
M-L Meyer, S Peters, T S Mok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.
Nature Communications
|
March 12, 2015
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Matthew J Niederst, Lecia V Sequist, John T Poirier, et al.
Page
of 53
Search research articles
Search
Showing results (451-460 of 524) with videos related to
Sort By:
Page
of 53
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in <i>KEAP1</i> mutant lung cancer
Ray Pillai, Sarah E LeBoeuf, Yuan Hao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2021
<i>KRAS</i> <sup>G12C</sup> Mutation Is Associated with Increased Risk of Recurrence in Surgically Resected Lung Adenocarcinoma
Gregory D Jones, Raul Caso, Kay See Tan, et al.
Oncotarget
|
October 29, 2013
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine
John Wrangle, Wei Wang, Alexander Koch, et al.
Cancer Discovery
|
July 5, 2022
PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry
Amish J Patel, Sarah Warda, Jesper L V Maag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2023
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer
Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, et al.
The New England Journal of Medicine
|
September 29, 2015
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
Hossein Borghaei, Luis Paz-Ares, Leora Horn, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 8, 2023
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis
Andreas Rimner, Zachary R Moore, Stephanie Lobaugh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2024
Lung cancer research and treatment: global perspectives and strategic calls to action
M-L Meyer, S Peters, T S Mok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.
Nature Communications
|
March 12, 2015
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Matthew J Niederst, Lecia V Sequist, John T Poirier, et al.
Page
of 53